Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays

Lassa virus (LASV), a mammarenavirus, infects an estimated 100,000–300,000 individuals yearly in western Africa and frequently causes lethal disease. Currently, no LASV-specific antivirals or vaccines are commercially available for prevention or treatment of Lassa fever, the disease caused by LASV....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Viruses
Hoofdauteurs: Caì, Yíngyún, Iwasaki, Masaharu, Beitzel, Brett F., Yú, Shuīqìng, Postnikova, Elena N., Cubitt, Beatrice, DeWald, Lisa Evans, Radoshitzky, Sheli R., Bollinger, Laura, Jahrling, Peter B., Palacios, Gustavo F., de la Torre, Juan C., Kuhn, Jens H.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6266387/
https://ncbi.nlm.nih.gov/pubmed/30463334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v10110655
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items